Breast cancer drug in bodybuilding supplements?

Image
IANS London
Last Updated : Feb 14 2014 | 5:25 PM IST

Are you on dietary supplements to build a robust body? Get alarmed as a breast cancer drug is reportedly being sold in bodybuilding dietary supplements.

Researchers warn that breast cancer drug tamoxifen - mixed in dietary supplements and used by bodybuilders to prevent and treat gynaecomastia (breast swelling) caused by anabolic steroid use - is being sold as a bodybuilding dietary supplement.

The researchers purchased four samples of a dietary supplement called 'Esto Suppress' and analysed its contents.

Tamoxifen was found in three out of the four samples at different concentrations. The product label suggested a dosage of two capsules a day.

"In the past, a growing number of off-the-shelf food, herbal, or dietary supplements - aimed at gym goers and people wanting to lose weight or enhance their sex lives - have contained pharmacologically active substances," claimed Dr Michael Evans-Brown of Liverpool John Moores University in Britain.

These include anabolic steroids, erectogenics (to stimulate erections), stimulants, appetite suppressants and anxiolytics (to treat anxiety).

Often the substances are not listed on the labelling and products may be marketed as 'natural,' said the study published in the British Medical Journal (BMJ).

"Most users would be unaware that they are taking these unhealthy substances," added Dr Brown.

A sound piece of advice from him: Read the label carefully and avoid body-building supplements completely.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 14 2014 | 5:22 PM IST

Next Story